Specialty chemical manufacturer Boyuan Corporation (301617.SZ) plans to make an initial public offering of 25.7 million shares.
Bo Yuan Shares (301617.SZ) released the prospectus for the first public offering of shares and the intention to list on the ChiNext board. The company...
Boyun Corporation (301617.SZ) released the prospectus for the initial public offering of shares and listing intention on the GEM, with the company planning to publicly issue 25.7 million shares, accounting for 25% of the total share capital after the issue. The preliminary inquiry date is November 25, 2024, and the subscription date is November 29, 2024.
It is reported that the company is a high-tech enterprise specializing in research, production, sales, and comprehensive utilization of fine chemicals. Its main business includes research, production, and sales of organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, hexamethyldisilazane, etc., and it also engages in recycling business of materials containing iodine, precious metals, etc., based on resource comprehensive utilization qualifications and technological advantages, providing customers with processing services of precious metal catalysts, hexamethyldisilazane, etc. The company's products and services are widely used in the fields of pharmaceuticals, chemical industry, optoelectronic materials, feed, food, etc.
The main products of the company include organic iodides used as chemical additives in the pharmaceutical manufacturing process, inorganic iodides used as additives or raw materials in the production of pharmaceuticals, pesticides, feed, food, optoelectronic materials, etc., precious metal catalysts used as catalysts in the pharmaceutical manufacturing process, luminescent materials used as chemical raw materials in emergency lighting, toy production, etc., and hexamethyldisilazane used as chemical additives in the pharmaceutical manufacturing process.
In the fiscal years 2021, 2022, and 2023, the company achieved a net profit attributable to the shareholders of the issuer of 103 million yuan, 176 million yuan, and 182 million yuan, respectively.
After deducting the issuance expenses from the funds raised in this new stock offering, the company will invest in the following projects in order of urgency: 1. 100 tons/year precious metal catalyst, 60 tons/year high-end luminescent new material, 4100 tons/year high-end organic iodine and bromine new material project, with a planned investment of 310 million yuan; 2. Annual production of 1000 tons of contrast agent intermediates, 5000 tons of para-phenylphenol project, with a planned investment of 208 million yuan; 3. Supplementary working capital, with a planned investment of 150 million yuan.
Related Articles

SINOPHARM (01099) announced its performance for the first three quarters, with a net profit attributable to the parent company of approximately 5.307 billion yuan, an increase of 0.53% year-on-year.

Hong Kong stock concept tracking | Constant positive news! Guangdong issued a document to support the high-quality development of low-altitude economy, highlighting investment opportunities in the industrial chain (with concept stocks)
.png)
Chongqing Sokon Industry Group Stock (09927) will be holding a global offering of 100.2 million H shares from October 27th to October 31st.
SINOPHARM (01099) announced its performance for the first three quarters, with a net profit attributable to the parent company of approximately 5.307 billion yuan, an increase of 0.53% year-on-year.

Hong Kong stock concept tracking | Constant positive news! Guangdong issued a document to support the high-quality development of low-altitude economy, highlighting investment opportunities in the industrial chain (with concept stocks)

Chongqing Sokon Industry Group Stock (09927) will be holding a global offering of 100.2 million H shares from October 27th to October 31st.
.png)
RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


